[Cytogenetic studies in renal carcinoma]

Area of Science:

• Oncology
• Cytogenetics
• Genetics

Background:

• Sporadic renal carcinoma is a significant health concern.
• Understanding the genetic underpinnings of renal carcinoma is crucial for diagnosis and treatment.
• Cytogenetic alterations are implicated in various cancers, but their role in sporadic renal carcinoma requires further elucidation.

Purpose of the Study:

• To investigate the cytogenetic profile of sporadic renal carcinoma.
• To explore correlations between karyotypic abnormalities and clinicopathological features.
• To assess the presence of clonal abnormalities in adjacent normal renal tissue.

Main Methods:

• Karyotyping was performed on 24 cases of sporadic renal carcinoma.
• Cytogenetic analysis was also conducted on normal renal tissue from 8 cases.
• Statistical analysis was used to correlate karyotype with tumor grade, stage, and diameter.

Main Results:

• Clonal chromosome changes were identified in 15 out of 24 (62.5%) renal carcinoma cases.
• Common alterations included loss of Y chromosome, gains of chromosomes 7 and 10, deletion at 3p, and rearrangement of chromosome 1.
• Cases with normal karyotypes were associated with low-grade tumors (Stage I).
• No correlation was found between karyotype and tumor diameter.
• In 8 cases, adjacent normal renal tissue exhibited clonal abnormalities similar to the tumor in 5 instances, and trisomy 7 in one case.

Conclusions:

• Cytogenetic abnormalities are frequent in sporadic renal carcinoma.
• Normal karyotypes may indicate a less aggressive tumor phenotype.
• The presence of similar clonal changes in adjacent normal tissue suggests early genetic events in renal carcinogenesis.
• These findings contribute to understanding the clinical significance of cytogenetic alterations in renal carcinoma.